Tag Archives: AstraZeneca

Novartis Names Jimenez CEO

By George Koroneos | Published: January 26, 2010
Novartis shocked investors on Tuesday morning when the Swiss-based firm announced that CEO Daniel Vasella would relinquish his post as CEO to Joe Jimenez while retaining his chairman of the board spot. According to a release, this move has been in the works since 2008 and lead to the restructuring of its management team. The executive [...]
Posted in Strategy | Also tagged , , , , | 1 Comment

AZ’s First Corporate Blog Falls Flat

By Andrew Sheivachman | Published: November 4, 2009
Currently, if patients or doctors look for specific drug information on AZ Health Connections, AstraZeneca’s new corporate communications blog, they won’t find any. And that’s exactly how AZ—along with pretty much every other pharma company engaged in the social media sphere—wants it. “The one area we’re trying not to engage is specific questions about disease state,” [...]
Posted in E-Media | Also tagged , , , , , , | 3 Comments

AstraZeneca, BMS Announce Layoffs and Buyouts

By George Koroneos | Published: October 21, 2009
AstraZeneca was the topic of conversation this week as word broke that the company is offering buyout deals to every member of its 5,500 US sales force. “AstraZeneca is making changes to our sales force, which will be managed first by looking at vacancies and offering field sales employees the opportunity to self-identify whether they are [...]
Posted in Strategy | Also tagged , , , , , , , | 1 Comment

Latest News from ASCO: Winners, Losers, and Also Rans

By Walter Armstrong | Published: June 3, 2009
Image via Wikipedia Due to pharma’s voluntary moratorium on doling out totefuls of freebies and all the lattes you can swallow, thousands of docs, researchers, and reporters had only their sleep-deprived selves to carry from data dump to data dump at this week’s American Society of Clinical Oncology (ASCO) annual confab in Orlando, Florida. Some 4,000 studies [...]
Posted in Events | Also tagged , , , , , | 2 Comments

AZ is All A-Twitter

By Brittany Agro | Published: February 11, 2009
When it comes to digital and social media, is Big Pharma finally getting it? Yesterday, AstraZeneca launched a branded YouTube channel for its asthma drug Symbicort, joining the ranks of Abbott, GSK, J&J, and most recently, Santofi-Aventis. This news arrived just in time for the 8th Annual ePharma Summit, where industry experts are gathered to [...]
Posted in E-Media, Events, Technology | Also tagged , , | 1 Comment